HR Execs on the Move

Organon

www.organon.com

 
At Organon, we envision a better and healthier every day for every woman. The diversity of our business provides a sustainable engine of growth so we can identify and invest in solutions for women. Our mission is to deliver impactful medicines and solutions for a healthier every day. We believe the journey to improve women`s health is critical to achieving a healthier world. We are united in our drive to better support the health of women within our company and around the globe. Together, we work toward our goal of finding solutions for the healthcare issues that matter most to ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $50-100 Million
  • www.organon.com
  • 30 Hudson Street
    Jersey City, NJ USA 07302
  • Phone: 551.430.6000

Executives

Name Title Contact Details
Taneha Boatwright
 Global Human Resources Director Profile
Jennifer Cole
 Director, Technology Solutions for HR/Talent Profile
Kristen Bridge
 Vice President, Head of Research and Development Portfolio and Business Operations Profile
Robyn Brown
 Executive Director, Finance Profile
Charlie Connors
 Finance Director Profile

Similar Companies

Celsion Corporation

Celsion Corporation is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Care Services

Care Services is a Eastlake, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Valeo Pharma

Founded in 2003, Valeo Pharma is a Canadian Pharma Company with a long history of successfully driving #healthcareinnovationforcanadians by commercializing pharmaceutical products in Canada and is therapeutically focused on respiratory diseases, neurodegenerative diseases, specialty products, and oncology.

Fisher Wallace Laboratories

The Fisher Wallace Stimulator® is a wearable neurostimulation device cleared by the FDA to treat depression, anxiety and insomnia. During each 20-minute treatment session, the device gently stimulates the brain to produce serotonin and other neurochemi...

Embecta

Embecta will be the name of the independent, publicly-traded company that will hold BD`s Diabetes Care business